CCM
Copernicus Capital Management Portfolio holdings
AUM
$8.26M
This Quarter Return
+31.74%
1 Year Return
+37.91%
3 Year Return
+125.34%
5 Year Return
–
10 Year Return
–
AUM
$76.3M
AUM Growth
+$76.3M
(-29%)
Cap. Flow
-$47.6M
Cap. Flow
% of AUM
-62.37%
Top 10 Holdings %
Top 10 Hldgs %
87.57%
Holding
20
New
4
Increased
1
Reduced
10
Closed
5
Top Buys
| 1 |
Cigna
CI
|
$8.18M |
| 2 |
Tandem Diabetes Care
TNDM
|
$2.98M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$1.96M |
| 4 |
Fate Therapeutics
FATE
|
$1.7M |
| 5 |
Ascendis Pharma
ASND
|
$1.67M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$12.5M |
| 2 |
Humana
HUM
|
$9.92M |
| 3 |
Centene
CNC
|
$6.36M |
| 4 |
Merck
MRK
|
$6.23M |
| 5 |
Thermo Fisher Scientific
TMO
|
$6.18M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vertex Pharmaceuticals
VRTX
$100B
| $12.7M | 16.6% |
57,815
-7,034
| -11% | -$1.54M |
|
2
BioMarin Pharmaceuticals
BMRN
$11.2B
| $10.5M | 13.74% |
123,958
-12,042
| -9% | -$1.02M |
|
3
Bristol-Myers Squibb
BMY
$96B
| $8.53M | 11.18% |
132,832
-65,105
| -33% | -$4.18M |
|
|
4
Cigna
CI
$80.3B
| $8.18M | 10.72% |
+40,000
| New | +$8.18M |
|
5
AbbVie
ABBV
$372B
| $6.81M | 8.93% |
76,957
-55,043
| -42% | -$4.87M |
|
6
IQVIA
IQV
$32.4B
| $6.27M | 8.22% |
40,585
-17,401
| -30% | -$2.69M |
|
7
Zoetis
ZTS
$69.3B
| $4.01M | 5.26% |
30,315
-60
| -0.2% | -$7.94K |
|
|
SIEN
8
DELISTED
Sientra, Inc.
SIEN
| $3.44M | 4.51% |
384,809
-191
| -0% | -$1.71K |
|
|
9
Thermo Fisher Scientific
TMO
$186B
| $3.24M | 4.24% |
9,959
-19,017
| -66% | -$6.18M |
|
|
10
Fate Therapeutics
FATE
$120M
| $3.17M | 4.16% |
161,977
+86,977
| +116% | +$1.7M |
|
|
11
Tandem Diabetes Care
TNDM
$845M
| $2.98M | 3.91% |
+50,000
| New | +$2.98M |
|
|
KRTX
12
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $1.96M | 2.57% |
+26,000
| New | +$1.96M |
|
|
13
Ascendis Pharma
ASND
$11.8B
| $1.67M | 2.19% |
+12,000
| New | +$1.67M |
|
|
14
Humana
HUM
$36.5B
| $1.45M | 1.89% |
3,942
-27,058
| -87% | -$9.92M |
|
15
Illumina
ILMN
$15.8B
| $1.43M | 1.87% |
4,309
-5,007
| -54% | -$1.66M |
|
16
CareDx
CDNA
$727M
| – | – |
-184,855
| Closed | -$4.18M |
|
|
17
Centene
CNC
$14.3B
| – | – |
-147,000
| Closed | -$6.36M |
|
18
Amicus Therapeutics
FOLD
$2.34B
| – | – |
-335,000
| Closed | -$2.69M |
|
|
19
Gilead Sciences
GILD
$140B
| – | – |
-197,916
| Closed | -$12.5M |
|
|
20
Merck
MRK
$210B
| – | – |
-74,000
| Closed | -$6.23M |
|